A significant breakthrough in cancer investigation is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This crucial malignant suppressor protein is frequently inactivated in several types of https://kbookmarking.com/story21935279/nanobodies-restore-the-p53-protein-a-new-pathway-for-malignant-management